Ketamine Completed Phase 1 Trials for Autism Spectrum Conditions/Disorders Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT02611921Study of Intranasal Ketamine for Social Impairment in Autism Spectrum Disorder